checkpoint inhibitors Archives - Page 23 of 24

Meet CRI’s New CEO Alicia Zhou, PhD

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Filter stories by:

European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma

July 22, 2015December 14, 2022 Matthew Tontonoz

Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer

July 20, 2015December 14, 2022 Matthew Tontonoz

New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer

July 7, 2015December 14, 2022 Matthew Tontonoz

Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma

March 24, 2015December 14, 2022 Matthew Tontonoz

What Cancer Patients Need to Know About the Opdivo Approval

March 13, 2015December 14, 2022 Emily Helck

Big News: FDA Approves Opdivo (Nivolumab) for Lung Cancer

March 4, 2015December 14, 2022 Matthew Tontonoz

1 … 21 22 23 24

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.